Sensei Biotherapeutics, Inc.
COMBINATION THERAPIES FOR CANCER
Last updated:
Abstract:
Disclosed herein are methods for treating cancer by administering to a subject a composition comprising a bacteriophage expressing a fragment of human aspartate .beta.-hydroxylase (ASPH) and an immune checkpoint protein inhibitor.
Status:
Application
Type:
Utility
Filling date:
1 May 2020
Issue date:
5 Nov 2020